Shanghai Pharmaceuticals Holding Co., Ltd. (SHPMF)
OTC
Closed
Aug 21, 2026
Day's Range
1.4652 wk Range
1.46Overview - SHPMF - Shanghai Pharmaceuticals Holding Co., Ltd.
Key Statistics
Valuation
Enterprise Value
5.54B
P/E (Trailing)
‪6.63‬
PEG Ratio
‪1.19‬
Price / Sales (TTM)
‪0.01‬
Price / Book
‪0.47‬
EV / EBITDA
‪3.43‬
Profitability
Gross Margin
‪10.75%‬
Profit Margin
‪2.01%‬
Operating Margin
‪3.49%‬
Return on Assets
‪2.38%‬
Return on Equity
‪8.12%‬
Ownership
Shares Outstanding
3.70B
Float
1.50B
Held by Insiders
‪40.05%‬
Held by Institutions
‪13.65%‬
Price stats
Beta
‪0.15‬
50-Day Avg
‪1.46‬
200-Day Avg
‪1.47‬
Dividends
Payout Ratio
‪18.94%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SHPMF - Shanghai Pharmaceuticals Holding Co., Ltd.
Peers - SHPMF - Shanghai Pharmaceuticals Holding Co., Ltd.
Peer Comparison
Compared with companies in Medical Distribution listed on OTC.
Profile Summary - SHPMF - Shanghai Pharmaceuticals Holding Co., Ltd.
About
Shanghai Pharmaceuticals Holding Co., Ltd. is a leading integrated pharmaceutical company based in China, involved in both the manufacture and distribution of pharmaceutical products. The company is pivotal in the healthcare sector, providing an extensive portfolio of over-the-counter drugs, prescription medications,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
